Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma
- DOI
- 10.1001/jamanetworkopen.2021.47375
- Published
- 2022-01-25
- Container
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1001/jamanetworkopen.2021.47375,
title = {Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma},
author = {Hyung Park and Thaddeus Tarpey and Mengling Liu and Keith Goldfeld and Yinxiang Wu and Danni Wu and Yi Li and Jinchun Zhang and Dipyaman Ganguly and Yogiraj Ray and Shekhar Ranjan Paul and Prasun Bhattacharya and Artur Belov and Yin Huang and Carlos Villa and Richard Forshee and Nicole C. Verdun and Hyun ah Yoon and Anup Agarwal and Ventura Alejandro Simonovich and Paula Scibona and Leandro Burgos Pratx and Waldo Belloso and Cristina Avendaño-Solá and Katharine J Bar and Rafael F. Duarte and Priscilla Y. Hsue and Anne F. Luetkemeyer and Geert Meyfroidt and André M. Nicola and Aparna Mukherjee and Mila B. Ortigoza and Liise-anne Pirofski and Bart J. A. Rijnders and Andrea Troxel and Elliott M. Antman and Eva Petkova},
year = {2022},
journal = {JAMA Network Open},
doi = {10.1001/jamanetworkopen.2021.47375},
url = {https://doi.org/10.1001/jamanetworkopen.2021.47375}
}RIS
TY - JOUR TI - Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma AU - Hyung Park AU - Thaddeus Tarpey AU - Mengling Liu AU - Keith Goldfeld AU - Yinxiang Wu AU - Danni Wu AU - Yi Li AU - Jinchun Zhang AU - Dipyaman Ganguly AU - Yogiraj Ray AU - Shekhar Ranjan Paul AU - Prasun Bhattacharya AU - Artur Belov AU - Yin Huang AU - Carlos Villa AU - Richard Forshee AU - Nicole C. Verdun AU - Hyun ah Yoon AU - Anup Agarwal AU - Ventura Alejandro Simonovich AU - Paula Scibona AU - Leandro Burgos Pratx AU - Waldo Belloso AU - Cristina Avendaño-Solá AU - Katharine J Bar AU - Rafael F. Duarte AU - Priscilla Y. Hsue AU - Anne F. Luetkemeyer AU - Geert Meyfroidt AU - André M. Nicola AU - Aparna Mukherjee AU - Mila B. Ortigoza AU - Liise-anne Pirofski AU - Bart J. A. Rijnders AU - Andrea Troxel AU - Elliott M. Antman AU - Eva Petkova PY - 2022 JO - JAMA Network Open DO - 10.1001/jamanetworkopen.2021.47375 UR - https://doi.org/10.1001/jamanetworkopen.2021.47375 ER -
APA
Park, H., Tarpey, T., Liu, M., Goldfeld, K., Wu, Y., Wu, D., Li, Y., Zhang, J., Ganguly, D., Ray, Y., Paul, S. R., Bhattacharya, P., Belov, A., Huang, Y., Villa, C., Forshee, R., Verdun, N. C., Yoon, H. A., Agarwal, A., Simonovich, V. A., Scibona, P., Pratx, L. B., Belloso, W., Avendaño-Solá, C., Bar, K. J., Duarte, R. F., Hsue, P. Y., Luetkemeyer, A. F., Meyfroidt, G., Nicola, A. M., Mukherjee, A., Ortigoza, M. B., Pirofski, L., Rijnders, B. J. A., Troxel, A., Antman, E. M., & Petkova, E. (2022). Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2021.47375
Source records
- crossref · retrieved 2026-09-26T17:06:43.663Z